text-only page produced automatically by LIFT Text Transcoder Skip all navigation and go to page contentSkip top navigation and go to directorate navigationSkip top navigation and go to page navigation
National Science Foundation Home National Science Foundation - Engineering (ENG)
Industrial Innovation and Partnerships (IIP)
design element
IIP Home
About IIP
Funding Opportunities
Awards
News
Events
Discoveries
Publications
Career Opportunities
I/UCRC Program Homepage
SBIR Program Homepage
See Additional IIP Resources
View IIP Staff
ENG Organizations
Chemical, Bioengineering, Environmental, and Transport Systems (CBET)
Civil, Mechanical and Manufacturing Innovation (CMMI)
Electrical, Communications and Cyber Systems (ECCS)
Engineering Education and Centers (EEC)
Emerging Frontiers in Research and Innovation (EFRI)
Industrial Innovation and Partnerships (IIP)
Proposals and Awards
Proposal and Award Policies and Procedures Guide
  Introduction
Proposal Preparation and Submission
bullet Grant Proposal Guide
  bullet Grants.gov Application Guide
Award and Administration
bullet Award and Administration Guide
Award Conditions
Other Types of Proposals
Merit Review
NSF Outreach
Policy Office
Additional IIP Resources
SBIR.gov
Other Site Features
Special Reports
Research Overviews
Multimedia Gallery
Classroom Resources
NSF-Wide Investments

Email this pagePrint this page


Press Release 10-094
Getting a Grip on Stroke Treatment

New device may provide safer way to treat the third leading cause of death in the U.S.

Medical illustration revealing how the SHELTER device traps and removes blood clots in the brain.

Illustration showing how the SHELTERTM device traps and removes blood clots in the brain.
Credit and Larger Version

June 8, 2010

View a video showing the SHELTERTM device in action and the May 27, 2010, webcast featuring the SHELTERTM technology and its developers.

When someone suffers a stroke, time is critical--more than a million brain cells die each minute, starved of nourishment due to critical damage in a cerebral blood vessel.

Now, researchers have developed a new tool for efficiently removing blood clots in the brain, the leading cause of strokes. The tool overcomes limitations in current emergency stroke treatments, potentially extending the time for a victim to get help.

Engineered with support from NSF's Small Business Innovation Research (SBIR) program, Insera Therapeutics, Inc. of Sacramento, Calif., developed the Stroke Help using an Endo-Luminal Transcatheter Embolus Retrieval (SHELTERTM) device.

Created by two brothers--Vallabh Janardhan, an interventional neurologist, and Vikram Janardhan, an engineer and the company's CEO--SHELTERTM is built upon a lengthy catheter. The device contains two primary components: an outer sheath for containing captured clots and an inner filament that houses the collapsible, five-millimeter-diameter, nickel-titanium mesh that grabs and filters the clots. To prevent accidental puncturing of blood vessels, the inner component also contains a soft, spring-like tip and a polymer safety coating.

"At the end of the day, ischemic strokes are simply a clog in a pipe," said Vikram Janardhan. "But such strokes are the leading cause of long-term disability in the United States. We ought to be able to leverage innovative technology to successfully treat this medical emergency."

The technology recently completed rigorous testing in a unique, water-filled test bed that was modeled in silicone from human-cadaver brain vessels. Complete with aneurysms, atherosclerosis and "plaque", the new test-bed is more accurate than certain animal tests, and has helped speed the device's development. Potentially, the test-bed could present a new approach to late-stage evaluation of certain medical technologies.

SHELTERTM is the first platform to both filter and remove clots, the first to entrap the clot from both its near and far ends, and the first capable of accessing small vessels in the brain. Critically, the technology can be custom-fit for the specific length and diameter of a patient's clot, a personalized approach that may improve treatment success.

"Blood clots and blood vessels are not all the same size and shape, so a one-size-fits-all removal device is not the best solution," said Greg Baxter, the NSF program director who has overseen Insera's work. "Personalized medicine is driving many new innovations, and Insera's approach follows this trend--they found a way to bring personalization to a potentially powerful treatment approach, and we're proud to have been a small part of this effort."

Strokes, or brain attacks, killed more than 130,000 Americans last year. In addition, strokes debilitate hundreds of people each day. An individual only has a few short hours to rush to the hospital, receive an accurate diagnosis, and then receive treatment to remove a debilitating blood clot before permanent brain damage occurs.

"Three hours allows an individual to get treatment from a stroke center as far as 65 miles away," said Vallabh Janardhan. "Extending the treatment window to eight hours extends the travel distance to 200 miles, a range that would enable 95 percent of the U.S. population to reach a certified stroke center. Potentially, hundreds of thousands of victims could be helped by the larger, eight-hour time window."

Current treatment for ischemic strokes (those involving a blood clot as opposed to a rupture) relies on a clot-dissolving drug that is effective up to three hours after onset of stroke symptoms; after three hours, the drug could cause systemic bleeding complications. As a result, even after 14 years of use, only three to four percent of all stroke patients benefit from the approach.

Medical devices, when used as an alternative to drug therapy, do not cause systemic bleeding complications and can extend the treatment time-window to as much as eight hours.

Clot retrieval devices currently in use have only modest success rates because they have difficulty removing entire clots and reaching the smallest blood vessels in the brain. They are also prone to releasing blood debris, which can cause secondary strokes in smaller blood vessels "downstream".

In emergency use, a interventional neurologist would deploy SHELTERTM using an approach similar to other catheter-based treatments, guiding a catheter from a blood vessel in the leg to the site of the clot.

The catheter would travel through the blockage--unlike blood flow, the metal device has no trouble penetrating clots--to its far side, where the net deploys. The interventional neurologist then carefully pulls the debris into a cylindrical trap that caps the outer length of the catheter.

The Janardhans improved and evaluated their system using months of simulated extractions on their unique testing apparatus. To create the apparatus, Insera contracted a company to create a transparent silicone replica from the brain vasculature of a plasticized human cadaver. Then, Insera added modifications (known in the trade as "severe disease burden") to accurately represent the arteries of a real stroke victim, an environment that is much more difficult to navigate than the arteries of a standard model or a laboratory animal. 

"If widely adopted, the approach could significantly cut animal testing for some medical devices and reduce overall product development costs by as much as ten percent," said Vikram Janardhan. "The silicone replica of the human brain can also be used as a humane alternative to train hundreds of physicians in the use of SHELTER."

The developers hope to run clinical trials of SHELTERTM in the U.S. in 2012 or 2013 and seek regulatory approval shortly thereafter.

-NSF-

Media Contacts
Joshua A. Chamot, NSF, (703) 292-7730, jchamot@nsf.gov

Program Contacts
Gregory T. Baxter, NSF, (703) 292-7795, gbaxter@nsf.gov

Principal Investigators
Vallabh Janardhan, Insera Therapeutics, (916) 849-0945, vallabh@inseratherapeutics.com

Co-Investigators
Vikram Janardhan, Insera Therapeutics, (916) 849-0945, vikram@inseratherapeutics.com

The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2014, its budget is $7.2 billion. NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and other institutions. Each year, NSF receives about 50,000 competitive requests for funding, and makes about 11,500 new funding awards. NSF also awards about $593 million in professional and service contracts yearly.

 Get News Updates by Email 

Useful NSF Web Sites:
NSF Home Page: http://www.nsf.gov
NSF News: http://www.nsf.gov/news/
For the News Media: http://www.nsf.gov/news/newsroom.jsp
Science and Engineering Statistics: http://www.nsf.gov/statistics/
Awards Searches: http://www.nsf.gov/awardsearch/

 

Shows how the SHELTER device works and demonstrates it removing a clot from a blood vessel in brain.
View Video
See the SHELTERTM device in action.
Credit and Larger Version

Photo of two researchers and webcast host in the studio.
View Video
On May 27, NSF hosted a webcast featuring the SHELTERTM technology and its developers.
Credit and Larger Version

Photo showing SHELTER device grabbing a simulated blood clot from within a silicone blood vessel.
The SHELTERTM device grabs a simulated blood clot from within a silicone "blood vess
Credit and Larger Version

Photo of the Insera SHELTER device, which is small enough to fit into tiny blood vessels in brain.
The Insera SHELTERTM device is minuscule and fits into tiny blood vessels in the brain.
Credit and Larger Version

Photo of silicone copies of human cadaver blood vessels with aneurisms, atherosclerosis, plaque.
The modeled environment for testing Insera's blood-clot removal device is shown here.
Credit and Larger Version



Email this pagePrint this page
Back to Top of page